Hepatic Extracellular Volume Fraction by CMR: A Novel Prognostic Marker in Tricuspid Regurgitation

View at publisher
Authors: Pablo Villar Calle, Robert S. Zhang, Edmund Naami, Lorenzo Sewanan, Mahniz Reza, Elizabeth Manowitz, Nicholas Chan, Pascal Spincemaille, Yi Wang, Jonathan W. Weinsaft, Jiwon Kim
Cited by: 5
References: 30

Abstract

BACKGROUND: Tricuspid regurgitation (TR) leads to systemic venous congestion and congestive hepatopathy, but conventional TR imaging parameters incompletely capture systemic consequences. Hepatic extracellular volume fraction (ECV) on cardiac magnetic resonance T1 mapping may reflect hepatic tissue remodeling and provide prognostic information beyond conventional risk markers. METHODS: Consecutive patients with moderate or greater TR who underwent cardiac magnetic resonance with hepatic T1 mapping were studied. Hepatic ECV was calculated using pre- and postcontrast T1 values and hematocrit. Patients were stratified by hepatic ECV tertiles. The primary end point was all-cause mortality. RESULTS: Among 234 patients (mean age, 65.6±15.8 years; 46.2% men), mean hepatic ECV was 37.7±9.0%, with tertile cutoffs at 32.5% and 41.3%. Higher hepatic ECV tertiles were associated with worse biventricular function and greater TR severity. Right ventricular ejection fraction decreased across tertiles (48.2% versus 48.5% versus 40.3%, P

Fields of Study & Subjects

Liver Disease and Transplantation Liver Disease Diagnosis and Treatment Cardiovascular Function and Risk Factors

Publication details

Journal / source
Circulation Cardiovascular Imaging
Publisher
Ovid Technologies (Wolters Kluwer Health)
Volume
19
Issue
3
Pages
e018988–e018988
Publication date
22 January 2026
Language
EN